Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.

Neuromuscul Disord 2019 01 22;29(1):5-13. Epub 2018 Nov 22.

Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Shandong University, Jinan, China; Mitochondrial Medicine Laboratory, Qilu Hospital (Qingdao), Shandong University, Qingdao, China; Brain Science Research Institute, Shandong University, Jinan, China. Electronic address:

Anti-mitochondrial antibodies, the hallmark of primary biliary cirrhosis, have been detected in many patients with idiopathic inflammatory myopathies and these anti-mitochondrial-antibody-associated idiopathic inflammatory myopathies frequently show unique characteristics. We detected anti-mitochondrial antibodies in Chinese idiopathic inflammatory myopathy and summarized the clinical findings of these anti-mitochondrial-antibody-positive patients. Of 136 patients, seven (5.15%) were found to be anti-mitochondrial-antibody-positive. Primary biliary cirrhosis was present in 2 of these 7 patients, chronic disease duration in 2 patients and asymmetrical muscle weakness in 4 patients. The mean disease course was 8.58 months, and the mean creatine kinase level was 2256.53 U/L. Myositis-specific antibodies were found in 3 patients. According to clinical features and muscle histopathological findings, 3 patients were classified as dermatomyositis, 2 as possible polymyositis and 2 as necrotizing autoimmune myopathy. Of the 6 anti-mitochondrial-antibody-positive patients receiving follow-ups of 12-83 months, they all showed marked clinical improvement. Our study indicates that anti-mitochondrial antibodies are relatively rare in Chinese idiopathic inflammatory myopathy patients. These patients generally show various clinical features and have favorable treatment outcomes. Anti-mitochondrial antibody testing may be helpful to confirm the diagnosis of idiopathic inflammatory myopathy, especially in patients with atypical manifestations.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09608966173148
Publisher Site
http://dx.doi.org/10.1016/j.nmd.2018.11.004DOI Listing
January 2019
6 Reads
2.638 Impact Factor

Publication Analysis

Top Keywords

idiopathic inflammatory
24
anti-mitochondrial antibodies
16
patients
12
inflammatory myopathy
12
inflammatory myopathies
12
clinical features
12
treatment outcomes
8
myopathy patients
8
primary biliary
8
biliary cirrhosis
8
chinese idiopathic
8
anti-mitochondrial-antibody-positive patients
8
idiopathic
6
inflammatory
5
antibodies
5
anti-mitochondrial
5
clinical
5
dermatomyositis polymyositis
4
patients clinical
4
polymyositis necrotizing
4

Similar Publications